$2.19 -0.03 (-1.35%)
11/6/2009 4:00 PM

Keryx Biopharmaceuticals (KERX)

CAPS Rating: 3 out of 5

A biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer.

Current Price $2.19 Mkt Cap $104.77M
Open $2.25 P/E Ratio 24.67
Prev. Close $2.22 Div. (Yield) N/A (N/A)
Daily Range $2.12 - $2.25 Volume 515,719
52-Wk Range $0.09 - $3.33 Avg. Daily Vol. 1,603,000

KERX News and Commentary

Caps

How do you think KERX will perform vs the S&P 500?

Add Stock to Watchlist

All Members

118 Outperform
10 Underperform
 

All-Star Members

27 Outperform
6 Underperform
 

Wall Street

2 Outperform
1 Underperform
 

Top KERX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

spadesnet (< 20)
Submitted September 24, 2009

This Company is on its way up. They produce life saving and life improving treatments and are the real deal when it comes to bringing them to market. Having recently lost a family member to cancer, and knowing what it is like to wish one of these… More

supez2004 (79.75)
Submitted March 03, 2008

Phase 3 for sulodexide unlikely to impress ...

KERX VS S&P 500 (SPY)

Fools bullish on KERX are also bullish on:

Recent Community Commentary

Read the most recent pitches from members about KERX.

Recs

0
Member Avatar sOulbAitIsAFool (< 20) Submitted: 10/18/2009 7:47:09 PM : Outperform Start Price: $2.22 KERX Score: +0.43

If you have a few extra coins, this is the one.

Recs

0
Member Avatar carsondyle (26.59) Submitted: 10/13/2009 11:30:12 AM : Outperform Start Price: $2.56 KERX Score: -16.60

Speculative buy, also really like the potential I see in SNGX.

Recs

0
Member Avatar rachisme73 (< 20) Submitted: 10/9/2009 1:36:18 PM : Outperform Start Price: $2.19 KERX Score: -0.22

Solid history until 2008, 2 new drugs in phase III trials with promise.

Leaderboard

Find the members with the highest scoring picks in KERX.

Score Leader

ValueRider

ValueRider (99.19) Score: +149.76

The Score Leader is the member with the highest score across all their picks in KERX.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score Commentary
MTF108 75.31 8/28/2006 Underperform 3W $12.05 -81.83% -11.92% +69.90
Made4WallStreet 72.39 12/29/2006 Underperform 1Y $13.39 -83.64% -19.95% +63.70
bsrobins 73.72 3/30/2007 Underperform 3M $10.51 -79.16% -20.38% +58.79
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. BicaChica 81.29 2/29/2008 Underperform 1Y $6.00 -63.50% -17.67% +45.83
supez2004 79.75 3/3/2008 Underperform NS $5.75 -61.91% -16.14% +45.77 2 Comments
mavericktrading 99.94 9/28/2009 Underperform 5Y $2.62 -16.41% +2.17% +18.59
tcampbellla 90.80 9/30/2009 Underperform 5Y $2.53 -13.44% +0.72% +14.16
cashole 84.14 9/17/2009 Underperform 3M $2.29 -4.37% +0.44% +4.81
athertonji 47.47 10/20/2009 Outperform 5Y $2.15 +1.88% -1.76% +3.64
jeffmwallace 32.72 10/26/2009 Outperform 5Y $2.15 +1.86% -1.70% +3.56

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackBearStearns 86.38 9/17/2009 Underperform NS $1.88 +16.49% +1.45% -15.04
TrackPZK < 20 9/16/2009 Outperform NS $1.88 +16.49% +1.45% +15.04
TrackBreanMurray 89.84 9/16/2009 Outperform NS $1.88 +16.49% +1.45% +15.04
TrackRodmanRen < 20 6/11/2007 Outperform NS $10.65 -92.96% -12.98% -79.97 3/10/2008 @ $0.75
TrackBofASec 93.50 11/2/2006 Outperform NS $13.51 -95.11% -5.05% -90.06 3/11/2008 @ $0.66

Featured Broker Partners